Aurora Cannabis Inc. is reporting 20 per cent higher revenue and a 33 per cent lower net loss for the first three months of 2019 compared with the last quarter of 2018.
The Edmonton-based company credited higher production and sales for a $158-million loss on net revenue of $65 million, compared with a loss of $238 million on revenue of $54 million in the prior quarter.
READ MORE: Aurora Cannabis shares higher after Peltz comes aboard
Watch below: Some Global News videos about Aurora Cannabis.
-
![]()
Behind-the-scenes tour of Aurora Sky -
![]()
Rolling in the green in Quebec -
![]()
Aurora Cannabis buys MedReleaf for $3.2 billion -
![]()
Aurora Cannabis CCO weighs in on Edmonton facility, job opportunities -
![]()
Major cannabis company calling Edmonton home with its world HQ -
![]()
Medical marijuana company Aurora Cannabis expands to Edmonton airport
Analysts had expected a net loss of $52.6 million on net revenue of $77 million in the quarter ended March 31, according to Thomson Reuters Eikon.
Aurora says it nearly doubled production to 15,590 kilograms, with the majority of the volume harvested in the last half of the quarter.
READ MORE: Aurora Cannabis plant working to contain skunky smell at Edmonton airport
It says Canadian consumer revenue rose 37 per cent to $29.6 million, exceeding medical revenue of $29.1 million, which was up 12 per cent.
The cost per gram of dried product fell to $1.42 from $1.92 but the average net selling price was also down, to $6.40 from $6.80.
“We achieved solid revenue growth and strong operating results in a quarter proven challenging across the industry. We are laser focused on building a long-term sustainable business,” said CEO Terry Booth in a release.
- Posters promoting ‘Steal From Loblaws Day’ are circulating. How did we get here?
- Canadian food banks are on the brink: ‘This is not a sustainable situation’
- Is home ownership only for the rich now? 80% say yes in new poll
- Investing tax refunds is low priority for Canadians amid high cost of living: poll
Comments